Table 3.

Heterogeneity of CTC sub-populations according to Cellsearch positivity before treatment with pazopanib.

Phenotype	CellSearch platform (N = 56)		p value
	≥5 CTCs (N = 28)	<5 CTCs (N = 28)
CK+/Ki67+	12 (42,8%)	18 (64,3%)	0,108
CK+/Ki67−	23 (82,1%)	16 (57,1%)	0,042
CK+/M30+	7 (25,0%)	1 (3,6%)	0,131
CK+/M30−	23 (82,1%)	18 (64,3%)	0,022
CK+/Vim+	25 (89,3%)	17 (60,7%)	0,014
CK+/Vim−	22 (78,6%)	10 (35,7%)	0,001